The New England journal of medicine, 2023-07, Vol.389 (2), p.107-117
- Lincoff, A. Michael
- Bhasin, Shalender
- Flevaris, Panagiotis
- Mitchell, Lisa M.
- Basaria, Shehzad
- Boden, William E.
- Cunningham, Glenn R.
- Granger, Christopher B.
- Khera, Mohit
- Thompson, Ian M.
- Wang, Qiuqing
- Wolski, Kathy
- Davey, Deborah
- Kalahasti, Vidyasagar
- Khan, Nader
- Miller, Michael G.
- Snabes, Michael C.
- Chan, Anna
- Dubcenco, Elena
- Li, Xue
- Yi, Tingting
- Huang, Bidan
- Pencina, Karol M.
- Travison, Thomas G.
- Nissen, Steven E.
2023
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Lincoff, A. Michael
- Bhasin, Shalender
- Flevaris, Panagiotis
- Mitchell, Lisa M.
- Basaria, Shehzad
- Boden, William E.
- Cunningham, Glenn R.
- Granger, Christopher B.
- Khera, Mohit
- Thompson, Ian M.
- Wang, Qiuqing
- Wolski, Kathy
- Davey, Deborah
- Kalahasti, Vidyasagar
- Khan, Nader
- Miller, Michael G.
- Snabes, Michael C.
- Chan, Anna
- Dubcenco, Elena
- Li, Xue
- Yi, Tingting
- Huang, Bidan
- Pencina, Karol M.
- Travison, Thomas G.
- Nissen, Steven E.
- Titel
- Cardiovascular Safety of Testosterone-Replacement Therapy
- Ist Teil von
- The New England journal of medicine, 2023-07, Vol.389 (2), p.107-117
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2023
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- In a randomized trial involving men with hypogonadism and preexisting or a risk of cardiovascular disease, testosterone therapy was noninferior to placebo with respect to major adverse cardiac events.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793eISSN: 1533-4406DOI: 10.1056/NEJMoa2215025Titel-ID: cdi_proquest_miscellaneous_2827262588
- Format
- –
- Schlagworte
- Aged, Aged, 80 and over, Aging, Aging General, Cardiology, Cardiology General, Cardiovascular disease, Cardiovascular diseases, Cardiovascular Diseases - chemically induced, Cardiovascular Diseases - epidemiology, Cerebral infarction, Clinical Medicine, Confidence intervals, Coronary Disease, Design, Diabetes Mellitus, Type 2, Double-Blind Method, Double-blind studies, Drug dosages, Embolism, Endocrinology, Endocrinology General, Enrollments, FDA approval, Gels, Geriatrics, Heart attacks, Heart failure, Hormone Replacement Therapy - adverse effects, Hormone Replacement Therapy - methods, Humans, Hypogonadism, Hypogonadism - blood, Hypogonadism - drug therapy, Laboratories, Male, Middle age, Middle Aged, Myocardial Infarction, Myocardial Infarction - epidemiology, Outpatient-Based Clinical Medicine, Patients, Placebos, Prevention, Prostate cancer, Prostate Disease, Prostate Disease General, Safety, Sensitivity analysis, Statistical analysis, Stroke, Stroke - epidemiology, Testosterone, Testosterone - adverse effects, Testosterone - blood, Testosterone - therapeutic use, Transdermal Patch, Urology